HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK CBD Market Buoyed By FSA Reassurance

Executive Summary

The UK's burgeoning CBD industry is responding positively to recent news that the Food Standards Agency will not crack down on unlicensed CBD products.  

You may also be interested in...



No Plans To Remove CBD Products From Shelves, Says UK Food Regulator

CBD products already on the UK market are safe for now, as the country's Food Standards Agency says it will not take action while it works out how to implement the new European Union novel food regulations. 

UK Cracks Down On Unauthorized CBD

In the last 12 months, 20 separate notices have been issued by the UK medicines agency to firms selling unauthorized CBD supplements in the country, according to data recently published by the regulator.

Prestige Expands UK Eye Care Range In Response To Consumer Demand

A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149684

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel